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Rocky Mountain  spotted  fever has  been for  the past 20 years  the
subject of study by various workers,  including members  of the United
States  Public  Health  Service.  The  discoveries  of  Wilson  and
Chowning,'  McCalla,2  King,3 Ricketts,4 Maver,5 Moore,'  Cooley,7
1 Wilson, L. B.,  and  Chowning,  W.  M.,  The  so-called  "spotted  fever"  of the
Rocky Mountains,  J. Am.  Med. Assn.,  1902, xxxix,  131;  Studies in Piroplasmosis
hominis.  "Spotted  fever"  or "tick  fever"  of  the  Rocky  Mountains,  J.  Infect.
Dis., 1904, i,  31.
2 McCalla, L. P., Direct transmission from man to man of the Rocky Mountain
spotted  (tick)  fever,  Med. Sentinel,  1908,  xvi, 87.
3 King, W. W., Experimental transmission  of Rocky Mountain  spotted fever by
means of the tick.  Preliminary note, Pub. Health Rep.,  U. S. P. H., 1906, xxi, 863.
4 Ricketts,  H. T.,  The  transmission  of Rocky  Mountain  spotted fever  by  the
bite of the  wood-tick  (Dermacentor occidentalis), J.  Am.  Med.  Assn.,  1906,  xlvii,
358; Further observations  on Rocky  Mountain fever and Dermacentor occidentalis,
1067;  The  r6le of  the  wood-tick  (Dermacentor occidentalis) in  Rocky  Mountain
spotted fever,  and  the susceptibility  of  local  animals  to this  disease-a prelimi-
nary  report,  1907,  xlix,  24;  Further  experiments  with  the  wood-tick  in  relation
to Rocky  Mountain  spotted  fever,  1278;  Observations  on the  virus and means
of transmission  of Rocky  Mountain  spotted  fever, J.  Infect. Dis.,  1907,  iv,  141.
5 Maver,  M.  B.,  Transmission  of  spotted  fever  by  other  than  Montana  and
Idaho  ticks, J.  Infect. Dis., 1911,  viii,  322; Transmission  of spotted  fever by the
tick in nature,  327.
6 Moore,  J.  J.,  Time  relationships  of  the  wood-tick  in  the  transmission  of
Rocky  Mountain  spotted fever, J.  Infect. Dis., 1911,  viii, 339.
7 Cooley,  R. A., Preliminary report  on the wood tick.  Dermacentor sp.  Sixth
Annual Report of  the State Entomologist  of Montana, Montana Agric. Coll. Exp.
Station, Bull. 75, 1909, 95; Tick control in relation to the Rocky Mountain spotted
fever,  Montana Agric. Coll. Exp. Station, Bull. 85,  1911.
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Parker,8 and Wolbach,9 have proved that the disease is transmitted to
man  by  a certain wood tick, Dermacentor venustus, which receives the
virus  from  infected  wild  rodents,  principally  gophers  or  Columbian
ground  squirrels  and  jack-rabbits  (Wilson  and  Chowning;  Parker).
Ricketts"° was  the  first to  transmit  the  disease  from  man  to guinea
pigs and  monkeys  by injecting  the blood  drawn  from spotted  fever
patients and, after having fed normal ticks on the infected guinea pigs,
to reproduce  the disease  again in normal guinea pigs  by allowing  the
infected  ticks  to feed on the  animals.  The  virus of  Rocky  Mountain
spotted  fever  can  be  maintained  in  the laboratory  for  an indefinite
time by animal passage,  which makes its experimental  study possible.
Several  strains  of  the  passage  virus 1l  maintained  in  the  guinea  pig
were  employed  in the  present  series  of  studies  on immunity.
Ricketts and Gomez'2 found that the serum from  guinea pigs which
had  recovered  from  the  disease  would  protect  normal  guinea  pigs
from infection when administered within 2 to 3 days after the injection
of  the infecting material.  The  strength  of  the serum was  such  that
0.3  to  0.5  cc.  was  required  to protect  against  1  cc.  of  virus  (1,000
infecting doses),  and these  investigators  were unable  to  enhance  the
8 Parker,  R. R.,  Tick  control  program  for  1919,  Montana State Bd. Entomol.,
Circular 1,  1919;  The  control  of  Rocky  Mountain  spotted  fever  in  the  Bitter
Root Valley, Montana State Bd. Entomol., Circular  1 (Revised), 1921.  3rd Biennial
Rep.,  Montana State Bd. Entomol.,  1917-18,  1919;  4th  Biennial Rep.,  Montana
State Bd. Entomol.,  1919-20,  1921.
9  Wolbach,  S. B., Studies  on Rocky  Mountain  spotted fever, J. Med. Research,
1919-20, xli, 1.
] 0 Ricketts, H. T., The study of  "Rocky Mountain  spotted fever"  (tick fever?)
by  means  of animal inoculations.  A preliminary  communication,  J.  Am.  Med.
Assn.,  1906, xlvii,  33.
I am indebted to Dr. L. D. Fricks, of the United States Public Health Service,
Dr.  S. B.  Wolbach,  of  Harvard  Medical  School,  and Dr.  R.  R.  Parker,  of  the
Montana  State  Board  of Health  and  United  States  Public  Health  Service,  for
their  cooperation  in  supplying  me  with  virus  and  ticks  on  numerous  occasions
since  1916.
12 Ricketts,  H.  T.,  and  Gomez, L.,  Studies  on  immunity  in  Rocky  Mountain
spotted fever.  The preventive and curative action of  a serum for spotted  fever,
and  the inefficiency  of  sodium  cacodylate  as a curative  agent  for  this  disease  in
guinea-pigs,  J.  Infect. Dis., 1908,  v,  221.
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potency by repeatedly injecting an immune  animal with virus.  They
accordingly  drew  the  tentative  conclusion  that the usefulness  of  the
serum  in  human  cases  would  be  practically  nil, especially  since  the
amount required  would  be prohibitive  when  translated into  terms  of
human  body  weight.  Ricketts'  work  was  not completed,  however,
and there seem to be no experimental data to indicate how a serum of
this kind might be developed so as to be of practical value.  The pur-
pose of the experiments  recorded here was  to study this problem  and
if possible  to produce an immune serum of at least  sufficient  potency
to  be useful  when  the  time  of infection  is definitely  known  and  the
injection of serum can be made soon after the inoculation of the virus,
as when a laboratory worker is bitten by an infected tick or accidentally
inoculates  himself with an instrument  charged with infected material.
Although  the  serum  of  guinea  pigs which  have  passed  through  a
severe  infection  has  a  degree  of  neutralizing  power  when  injected
at the same  time  as the  virus,  it is not  strong enough  to  check  the
course  of the infection when introduced  24 to 48 hours later.  In the
present  series  of  experiments,  however,  it has  been  found  that  the
neutralizing  power  of  the  serum  is  considerably  increased  by  one
or  two more  subsequent  inoculations  of  the virus,  in citrated  blood,
into the  convalescent  guinea  pig,  and sera  prepared  in this way  are
capable  of modifying the course of the disease into a non-fatal one or,
in  some instances,  of  suppressing  the infection  completely,  provided
the serum is administered  during the incubation period.
The  small size  of  the guinea pig precludes  the possibility of  utiliz-
ing its immune  serum for  human  cases,  but the principle  developed
from  the experiments  with  the  serum  of  guinea  pigs  suggested  that
larger  animals  might  be  capable  of  furnishing  an  equally  potent
immune  serum in correspondingly  greater  amounts.
Ricketts  and  Gomez,'2 and  later  Heinemann  and  Moore,13  reported  having
infected horses by injecting large quantities  of virus from guinea pigs or monkeys.
Although  the horses  showed  some fever on the 3rd or 4th day after inoculation,  it
never reached  1040F. and usually lasted only 1 day.  The  serum from the horses,
however, was stated to possess some neutralizing power as compared  with  normal
horse  serum.
1' Heinemann,  P.  G., and Moore, J.  J., Experimental  therapy of Rocky  Moun-
tain spotted fever, J.  Infect. Dis., 1912,  x, 294.
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EXPERIMENTAL.
The writer's experiments with horses have so far been  unsuccessful.  Two adult
horses  were  given  intravenous  injections  of  blood  from  infected  guinea  pigs  in
doses ranging from  20 to 50 cc.  at intervals  of 3  to 5 days, and a colt 6 months old
received  similar injections  of larger  amounts (35  to 95  cc.)  of the virus.  The rise
of temperature  to  103-104°F.  which  occurred on the 3rd or 4th  day after  inocula-
tion was interpreted  as being due  to the introduction of a  large quantity  of blood
corpuscles  from  a  foreign  species.  The  animals  never  showed  symptoms  sug-
gestive  of  spotted  fever,  and  the  serum  on  test  was  found  to  have  only slight
neutralizing  power for the virus; 1 cc.  was necessary to neutralize about  10 M.L.D.
when  administered  simultaneously.
In view of the facts that adult ticks feed on horses and cattle, and that a certain
number of ticks collected at random prove to be infective, it was thought of interest
to test the serum of horses which had been pastured  in infected districts.  Serum
from a horse which had been pastured for several years in the Bitter Root  Valley
was  obtained' 4 and  tested  against  the  virus.  As  shown  in Table  I  this  serum
(No.  1) in  a  dose of  3 cc.  gave  complete  protection  against  1 cc.  (approximately
100 M.L.D.)  of the  spotted fever virus when injected simultaneously.  Of the other
three  sera  subsequently  obtained  from horses  pastured  in  the  same  region,  one
(No.  2),  which  was  contaminated  on  arrival,  failed  to  give  any  protection  in  a
dose  of 3 cc.,  while Sera  3 and 4 had definite  neutralizing power, the animals  re-
ceiving  3  cc.  of the serum simultaneously  with  100 M.L.D.  of  the virus recovering
after  a typical  febrile  reaction  without  scrotal  or  skin  lesions.
TABLE  I.
Administration of Serum from Horses Pastured for Several Years in  the Bitter Root
Valley  of Montana to Guinea Pigs Inoculated with  100 M.  L.  D. of the  Rocky
Mountain Spotted Fever Virus.
Serum  No.  Date.  Amount.  Result.  Remarks.
1922  cc.
1  Feb.  3  3  No infection.  Tested  for  immunity  after  40
days  and  found  to  be  com-
pletely immune.
1  Apr.  2  3  G"  "  Died  of  intercurrent  infection
before  test  for  immunity
could  be  carried  out.
2  "  25  3  Typical infection.  Died  in  13  days.
(contaminated
on arrival).
3  "  25  3  "  fever  for  4  Recovered without lesions.
days.
4  "  25  3  Typical  fever for 5 
days.
14 The  serum  was obtained  through  the kindness  of Dr. W. J. Butler  and  Dr.
Hadleigh Marsh, of the Montana Livestock  Sanitary Board.
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The  only animal  which  yields a useful serum, both in potency and
quantity,  is  the rabbit.  In  the first place,  the  rabbit  is susceptible
to  the  virus  of  spotted  fever.  The  infection  is  usually  non-fatal,
the febrile period lasting for 6 to 9 days,  though it is sometimes shorter
or longer.  The scrotal skin may show the typical capillary thrombosis
and  subsequent  necrosis.  After  recovery  the  animal  becomes  com-
pletely  resistant  to  subsequent  infection,  and  0.5  to  0.1  cc.  of  the
serum,  collected  2 weeks after disappearance  of symptoms,  is capable
of rendering non-fatal an infection produced by  100  M.L.D.  of the virus,
the test animal  in every  instance being the  guinea pig.  By  another
intravenous  injection  of  virulent  blood,  e.g.  of  4  cc.,  or  400  M.L.D.,
the serum  can be  raised  in  potency  five-  to  tenfold,  and in some  in-
stances  to such  a  titer that  0.1  cc.  will neutralize  1,000  M.L.D.  The
reinforcing  injection  is given  2 weeks  after  complete  recovery  of the
animal,  and  the  immune  serum  is  drawn  9  days  later.  A  serum,
whether  convalescent  or reinforced,  is sufficiently  strong  for practical
use when  it is capable  in  a  dose  of 0.1  cc.  of  neutralizing  100  M.L.D.
of  the virus.  As  will be seen  from the results  recorded  in  Tables  II
to  IV,  the  immune  rabbit  serum  prevents  the  development  of  the
infection or renders it non-fatal when administered within the period
of  incubation-the  earlier  the administration  of  the serum  the  more
complete  the suppression of the infection.
Male guinea  pigs  of  500  gm. body weight  were  used.  The virus '"
consisted  of  the citrated  blood from  the heart  of  guinea  pigs  on  the
4th or  5th day  of  fever  and  was  inoculated  subcutaneously.  1 cc.,
equivalent to 100 M.L.D.,  was given in Experiment 1, 0.1  cc.  (10 M.L.D.)
in Experiment  2,  and 0.01  cc.  (1 M.L.D.)  in Experiment  3.  Eighteen
guinea  pigs  were  used  in  each  series,  two  animals  being inoculated
with  the immune  serum  immediately  after the injection of  the virus,
and two at the end of 24,  48,  72, and  96  hours, and  5,  6, and 7 days.
The remaining two animals served as controls without serum.  The im-
mune  serum used was  a mixture  of sera from  several immunized rab-
bits  and was given  in a dose  of  1 cc. in Experiments  1 and  2 and 0.1
cc.  in  Experiment  3.  The  titer  of  the  pooled  serum  was  such  that
when  given  simultaneously  1 cc.  completely  neutralized  100  M.L.D.,
15 These  experiments  were  carried out  with a strain furnished  by Dr. Parker.
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Experiment 1.  Administration of Immune Rabbit Serum to Guinea Pigs Inoculated
with  100 M.  L.  D.  of  the Rocky  Mountain Spotted Fever Virus.
Amount of  serum,  1 cc.  uniformly.
Interval before serum
administration.
Immediately  after
inoculation.
Immediately  after
inoculation.
hrs.
24
24
48
48
72
72
96
96
days
5
5
6
6
Symptoms before serum
administration.
None.
c¢
Temperature
morning.
1050F.  in
Feser for 2 days.
High fever for a day.
..  "  (105-107°
F.) for 2 days.
High fever for 2 days.
Symptoms after serum
administration.
None.
Temperature rose to 104.50
F.  in  7 days;  remained
high  for  24  hrs.  Re-
covered.
High  fever developed  in 9
days; lasted  for  4 days.
No  scrotal  lesions.
Recovered.
High fever on 6th day; re-
mained for 4 days.  No
scrotal  lesions.  Re-
covered.
High fever for 3 days after
5th  day.  No  scrotal
lesions.  Recovered.
High  fever  continued  for
5  days.  No  scrotal
lesions.  Recovered.
High  fever  in  7  days,
lasting  48  hrs.  No
scrotal  lesions.  Re-
covered.
No  abatement  of  temper-
ature.  Typical  course.
Died in 16 days.
Fever  continued  at  105-
106.5°F.  for  8  days.
Died  in  17  days.
No  fall  in  temperature.
Typical  course.  Died
in 13 days.
No  reduction  in  fever.
Typical course.  Died in
13 days.
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Guinea pig No.
1A
1B
2A
2B
3A
3B
4A
4B
5A
5B
6A
6B
7A
7BHIDEYO  NOGUCHI
TABLE  II-Concluded.
Interval before serum  Symptoms  before serum  Symptoms after serum
Guinea pig  No.  administration.  administration.  administration.
days
8A  7  High  fever for  3  days.  Apparently  no  effect  on
the  course  of  infection.
Died in 13 days.
8B  7  "  "  "  3  "  No beneficial  effect.  Typ-
ical  course.  Died  in  12
days.
Controls with-
out serum.
9A  Temperature  105
0F. after  96 hrs.  and  remained  high for  5  days;  fell to
subnormal  on  the 11th day.  Scrotum,  ears,  and  feet showed  typical
lesions.  Died  in  12  days.
9B  Rise  of  temperature  to  104.5°F.  in 96  hrs.;  continued  high  for  7  days.
Died in 13 days.
0.1  and  0.01  cc.  modified  the  infection  to  a  non-fatal  one,  while
0.001  cc.  exerted  no  influence  upon the course of  the infection.  The
serum  was given  subcutaneously.
As Table II shows, 1 cc.  of  the serum,  given  within 24  hours from
the time of introduction  of a massive amount (100 M.L.D.)  of the virus
into the body of the guinea pig, is capable of suppressing the infection;
when given  later, but before 96 hours  (near the  time of  onset of  the
disease),  this  quantity  does  not  suppress  the  infection  but  renders
it non-fatal.  After  5 days,  that is when  the disease  is already mani-
fest,  no  benefit  seemed  to  be  derived  from  administration  of  the
serum,  the  animals  dying  within  12  to  17  days  (the  controls  died
within  12  to  13  days).
The  results  in  the  second  series  (Table  III)  are  similar,  except
that,  owing probably  to  the  smaller  quantity  of  the  virus used  (10
M.L.D.),  the infection  was  completely  suppressed  in all animals  which
received the serum within the first 48 hours.  All those which received
it after 48 hours, but within 96 hours,  survived, after passing through
a  mild  infection  without  any  scrotal  or  other  cutaneous  lesions.
Administration  of  the  serum  later  than  5 days  invariably  failed  to
prevent  a  fatal  outcome,  the  animals  dying  just as  the controls did.
In  the third  series  (Table IV),  in  which only  1 M.L.D.  was  used  to
infect  the  animals,  the  protective  effect  of  the  immune  serum  was
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Experiment 2.  Administration of Immune Rabbit Serum to Guinea Pigs Inoculated
with 10  M.L.D.  of  the Rocky  Mountain Spotted Fever Virus.
Amount  of serum,  1 cc. uniformly.
Interval before serum
administration.
Immediately  after
inoculation.
Immediately  after
inoculation.
hrs.
24
24
48
48
72
72
96
96
days
5
5
6
6
7
7
Symptoms before serum
administration.
None.
First sign  of fever (1050
Beginning  of fever.
. high fever.
High fever for  24 hrs. "  high  fever"
cc  48 
Symptoms  after serum
administration.
None.
it
High  fever  afte  5 days;
lasted only 3 days.
Recovered.
High  fever  after  5  days;
lasted  4  days.  Recov-
ered.
High  fever  developed in  7
days; lasted 2  days.  No
scrotal  lesions.  Recov-
ered.
High  fever  in  7  days;
lasted 5 days.  No scro-
tal lesions.  Recovered.
Fever continued for 7  days.
Typical  infection.  Died
in  12 days.
High  fever  continued  for
8  days.  Died  in  13
days.
Fever  of  typical  course.
Died in  13 days.
Fever  remained  high  for
7  days.  Died  in  14
days.
No influence on the course
of  the  infection.  Died
in  13 days.
Fever  for  5  days.  Typ-
ical course.  Died in  12
days.
Temperature  105.20F. in  5 days;  remained high for  7 days.  Died  in
13 days.
Temperature  1050F.  in  5 days;  remained  high  for  6  days.  Died in  12
days.
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Guinea pig No.
10A
1OB
11A
11B
12A
12B
13A
13B
14A
14B
15A
15B
16A
16B
17A
17B
Controls with-
out serum.
18A
18BHIDEYO  NOGUCHI
TABLE  IV.
Experiment 3.  Administration of Immune Rabbit Serum to Guinea Pigs Inoculated
with  1  M.L.D.  of the  Rocky Mountain Spotted Fever Virus.
Amount of serum,  0.1  cc. uniformly.
Interval before serum
administration.
Immediately  after
inoculation.
Immediately  after
inoculation.
hrs.
24
24
48
48
72
72
96
96
days
5
5
6
6
7
7
iSymptoms before serum
administration.
None.
i' 4'
cc
i
cc
Temperature  105°
F. in the morning
Temperature  1060
F. in the morning.
None.
cc
Temperature  105.5°
F. for 24 hrs.
Symptoms after serum administration.
None.
'C
C~
C'
Fever  in 7 days;  lasted 5 days.
Recovered.
Fever  in 7 days;  lasted  48  hrs.
Recovered.
Fever lasted  for 8 days.  Typ-
ical  scrotal  lesions.  Died
in  16  days.
Fever remained high for 7 days.
Typical  infection.  Died  in
14 days.
Temperature  1060F. in  9  days;
lasted  48  hrs.  Recovered.
Fever in 9 days; remained  high
3 days.  Recovered.
Fever and  scrotal  lesions  typ-
ical.  Died in 17 days.
Temperature  rose to  105.50F. in 5 days; lasted  for 9 days.  Scrotal skin
necrotic; ears  hardened.  Died in 18 days.
Temperature  1050F. in 7 days; lasted for 8 days.  Scrotal lesions  typical.
Died in 16 days.
Guinea  pig No.
19A
19B
20A
20B
21A
21B
22A
22B
23A
23B
24A
24B
25A
25B
26A
26B
Controls with-
out  serum.
27A
27B
much  more  pronounced  than  in  the  first  two  series.  Here  the  in-
fection  was  completely  suppressed  when  0.1  cc.  of  the  serum  was
given within  72 to 96 hours.  In one of each set of two animals treated
l
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with the  serum  after 5,  6,  and  7 days respectively,  the  infection  was
mild,  undoubtedly  because  the  serum  was  given  before  the  animals
showed  any  fever,  while  they  were  still  in  the  incubation  period,
which is  decidedly longer  in the  case of  1 M.L.D.  than when  10  or  100
M.L.D.  are inoculated.
DISCUSSION  AND  SUMMARY.
From  the  results of  the experiments  presented  it is evident  that in
guinea  pigs  an  early  administration  of  immune  rabbit  serum  will
suppress the infection; that is, if it is given within the period of incuba-
tion,  the  effect  being  proportionately  greater  the  earlier  the  serum
is  administered.  Almost  no  beneficial  effect  is  observed  when  the
serum is given after the onset  of  the  disease.  In  the  animals  inocu-
lated with  10 to  100 M.L.D.  the incubation period is shorter than when
1 M.L.D.  is injected;  nevertheless  1 cc.  of the  immune serum  saved  the
animals  as late as  96  hours from  the  time of  the introduction  of  the
virus  into  the  system.  When  administered  within  24  hours  in  the
case  of  100  M.L.D.  and  within  48  hours  in  the  case  of  10  M.L.D.,  the
serum  completely  neutralized  the  virus,  and  the  animals  escaped
infection  altogether.  On  the  other  hand,  the  same  quantity  of  the
serum only modified  the  infection  into  a  non-fatal  one  when  given
a  day  or  two later.  In  the  animals  which  were  inoculated  with
1 M.L.D.  the incubation  period  was  a  day or  two longer, and the neu-
tralizing effect of the serum was much more powerful.  Here animals
were saved as late as 5, 6, and 7 days and with a much smaller quantity
of the serum (0.1 cc.).
As  to  the  usefulness  of  such  an  immune  serum  in  human  cases,
the  relative  susceptibility  of  man  and  the  guinea  pig  must  first  be
considered.  In  a  large  number  of  experimental  infections  carried
out with  guinea pigs in  the past 6 years  almost never has  a naturally
refractory  animal  been  encountered.  The  mortality  is  nearly  80
per cent with most strains,  although as low as  50 per cent with some.
The  strain  used  in the  present  study  caused  death  in nearly  80  per
cent  of  the  animals.  Hence  the  susceptibility  of  guinea  pigs  is  at
least  as  great  as  that  of  man,  in  whom  the  mortality  in  the Bitter
Root Valley is estimated to be about 70 per cent.'?9
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The  relative  length  of  the  incubation  period  in  guinea  pig and  in
man  is  another  point  which  requires  analysis.  In  guinea  pigs  it
varies  somewhat  according to the number of passages,  being as short
as 3 days when  100  M.L.D.  or more of an  adapted virus are inoculated.
On the other hand,  when the  infection  is  the result  of  1 M.L.D.  or the
bite of  an  infected  tick,  the incubation  period  is  much longer,  being
5, 6, or 7 days in the former and 7 to 8  days in the latter instance, as
with the present  strain.  In  man  the  infection  is  brought  on  by the
bite of an infected  tick,  and the  period  of  incubation  varies  from  3
to 10 days but is usually 7 days; i.e., it is about the same as in guinea
pigs  infected  with 1 M.L.D.  Hence  we may  regard  the susceptibility
of man and the guinea pig as nearly equal.
The final point to be considered is the quantity of the immune serum
that may be recommended  for use in human  cases.  To  prevent  the
infection  in a guinea pig weighing  500 gm.,  0.1 cc. of  the  serum was
sufficient.  This quantity protected  the animal  against  1 M.L.D.  even
as late as 5, 6, or 7 days.  Calculated on this basis,  16 cc. of the serum
would be required for a man weighing 80 kilos (about 160 pounds); that
is, 16  cc. of an immune rabbit serum,  administered  before onset of the
disease,  should  theoretically  be  sufficient  to save  a  man  of  average
weight  against an infection  brought  about by the bite of  an infected
tick  or  by  a  laboratory  accident.  It  would  probably  be  best  to
administer  the serum intravenously.  The  titer of the immune serum
should  be  previously  determined  in  guinea  pigs,  and  1 cc.  should
neutralize  100  M.L.D.  completely  and 0.1  and  0.01  cc.  render  the  in-
fection non-fatal.  Such a serum is easily produced in rabbits (a rabbit
weighing 2,500  gm.  will yield 50 to 60  cc.  of  the serum)  and probably
will  remain  active  a  year  or  longer  when  kept  at  refrigerator
temperature.
CONCLUSIONS.
A  potent  immune  serum  against  the  virus  of  Rocky  Mountain
spotted fever  can be produced  in the rabbit.
By early  administration  of  such  an  immune  serum  the  virus  in-
troduced  into  the  guinea  pig  can  be  prevented  from  multiplying
and causing  fatal  infection.  When  given  within  the  period  of  incu-
bation  the  suppression of the infection  is  assured,  but after the  onset
of  the disease  the serum  has no  beneficial  effect.
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In view  of  the  comparative  susceptibility  of  man  and  the  guinea
pig it is recommended  that in every instance  when  the bite  of a tick
gives  reason  to  suspect  a  possible  infection  with  spotted  fever,  or
when  a person  accidentally  inoculates  himself  with the  virus,  about
0.2  cc. of the serum per kilo of body weight (or 0.1  cc. per pound) be
injected  immediately,  preferably  intravenously.  For  the  average
adult  about  16  cc.  should be  given.